Furiex Pharmaceuticals, Inc. (FURX) Misses Q1 EPS by 62c

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) reported Q1 EPS of ($1.25), $0.62 worse than the analyst estimate of ($0.63). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $10.01 million.

For earnings history and earnings-related data on Furiex Pharmaceuticals, Inc. (FURX) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Freedom Broker Starts Autoliv, Inc. (ALV) at Buy
• Bernstein sees downside risk to Apple's December quarter results